Truist Securities Maintains Buy on Evolus, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Gregory Fraser maintains a Buy rating on Evolus (NASDAQ:EOLS) and raises the price target from $14 to $18.
May 26, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Evolus and raises the price target from $14 to $18.
The news of Truist Securities maintaining a Buy rating on Evolus and raising the price target from $14 to $18 is positive for the stock. This indicates that the analyst believes the stock has potential for growth and is likely to perform well in the short term. As a result, the stock price is expected to go up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100